Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Masayuki Tojikubo"'
Autor:
Eiji Kawasaki, Takahiro Fukuyama, Aira Uchida, Yoko Sagara, Yuko Nakano, Hidekazu Tamai, Masayuki Tojikubo, Yuji Hiromatsu, Nobuhiko Koga
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 4, Pp 738-740 (2022)
Abstract Interleukin‐6 is a pleiotropic cytokine that plays a pathogenic role in type 1 diabetes. Therefore, anti‐interleukin‐6 receptor antibody, tocilizumab, used for the treatment of rheumatoid arthritis, is considered a candidate for immune
Externí odkaz:
https://doaj.org/article/6f3791905db6491caaa8af6a29ed0a8a
Autor:
Eiji Kawasaki, Takahiro Fukuyama, Aira Uchida, Yoko Sagara, Hidekazu Tamai, Yuko Nakano, Masayuki Tojikubo, Yuji Hiromatsu, Nobuhiko Koga
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 6, Pp 1507-1510 (2020)
Abstract This study aimed to characterize diabetic patients incidentally found to be positive for glutamic acid decarboxylase autoantibodies (GADA) in general practice. Using bridging‐type enzyme‐linked immunosorbent assay, we screened 1,040 pati
Externí odkaz:
https://doaj.org/article/cda2fb21e4d24c82a6dcb44c219f78bb
Autor:
Eiji Kawasaki, Takahiro Fukuyama, Erisa Kuriyama, Aira Uchida, Yoko Sagara, Hidekazu Tamai, Yuko Nakano, Masayuki Tojikubo, Nobuhiko Koga
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 6, Pp 1673-1676 (2020)
Abstract Statins are widely used medications for the treatment of hypercholesterolemia, as well as prevention of cardiovascular disease. We report two patients with type 1 diabetes who developed autoimmune hepatitis after the administration of statin
Externí odkaz:
https://doaj.org/article/a806a79d04f84e3bb5b75447e0283c8b
Autor:
Eiji Kawasaki, Akira Okada, Aira Uchida, Takahiro Fukuyama, Yoko Sagara, Yuko Nakano, Hidekazu Tamai, Masayuki Tojikubo, Nobuhiko Koga
Publikováno v:
Journal of Diabetes Investigation, Vol 10, Iss 4, Pp 990-996 (2019)
Abstract Aim/Introduction Autoantibodies to the 65 kDa isoform of glutamic acid decarboxylase (GADA) are a valuable diagnostic and predictive marker for type 1 diabetes. Recently, it has been reported that a significant proportion of sera in the comm
Externí odkaz:
https://doaj.org/article/5167460efa6947759d500f612f5be49d
Publikováno v:
Annals of Clinical & Laboratory Science; Sep/Oct2024, Vol. 54 Issue 5, p699-705, 7p
Autor:
Yuji Hiromatsu, Hidekazu Tamai, Nobuhiko Koga, Eiji Kawasaki, Yoko Sagara, Aira Uchida, Yuko Nakano, Masayuki Tojikubo, Takahiro Fukuyama
Publikováno v:
Journal of Diabetes Investigation. 13:738-740
Interleukin-6 is a pleiotropic cytokine that plays a pathogenic role in type 1 diabetes. Therefore, anti-interleukin-6 receptor antibody, tocilizumab, used for the treatment of rheumatoid arthritis, is considered a candidate for immune intervention i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb381432b74d17b56e81a8fd63b90353
https://doi.org/10.1111/jdi.13706
https://doi.org/10.1111/jdi.13706
Autor:
Nobuhiko Koga, Aira Uchida, Masayuki Tojikubo, Yuko Nakano, Yoko Sagara, Hidekazu Tamai, Eiji Kawasaki, Erisa Kuriyama, Takahiro Fukuyama
Publikováno v:
Journal of Diabetes Investigation
Journal of Diabetes Investigation, Vol 11, Iss 6, Pp 1673-1676 (2020)
Journal of Diabetes Investigation, Vol 11, Iss 6, Pp 1673-1676 (2020)
Statins are widely used medications for the treatment of hypercholesterolemia, as well as prevention of cardiovascular disease. We report two patients with type 1 diabetes who developed autoimmune hepatitis after the administration of statin. The fir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a5687d87c79ebcc3710d2bfba34ffc4
http://europepmc.org/articles/PMC7610114
http://europepmc.org/articles/PMC7610114
Autor:
Akira Okada, Hidekazu Tamai, Eiji Kawasaki, Masayuki Tojikubo, Takahiro Fukuyama, Yoko Sagara, Nobuhiko Koga, Aira Uchida, Yuko Nakano
Publikováno v:
Journal of Diabetes Investigation, Vol 10, Iss 4, Pp 990-996 (2019)
Journal of Diabetes Investigation
Journal of Diabetes Investigation
Aim/Introduction Autoantibodies to the 65 kDa isoform of glutamic acid decarboxylase (GADA) are a valuable diagnostic and predictive marker for type 1 diabetes. Recently, it has been reported that a significant proportion of sera in the commercial RS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a8183297ec158829ce50fd37716c4c6
https://doi.org/10.1111/jdi.12996
https://doi.org/10.1111/jdi.12996
Autor:
Hidekazu Tamai, Eiji Kawasaki, Masayuki Tojikubo, Nobuhiko Koga, Yoko Sagara, Yuji Hiromatsu, Takahiro Fukuyama, Aira Uchida, Yuko Nakano
Publikováno v:
Journal of Diabetes Investigation
Journal of Diabetes Investigation, Vol 11, Iss 6, Pp 1507-1510 (2020)
Journal of Diabetes Investigation, Vol 11, Iss 6, Pp 1507-1510 (2020)
This study aimed to characterize diabetic patients incidentally found to be positive for glutamic acid decarboxylase autoantibodies (GADA) in general practice. Using bridging‐type enzyme‐linked immunosorbent assay, we screened 1,040 patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::248eddcd197058ce52ff82df24cfbf26
https://pubmed.ncbi.nlm.nih.gov/32469160
https://pubmed.ncbi.nlm.nih.gov/32469160
Autor:
Satoe Nakamura, Eiji Sadasima, Masayuki Tojikubo, Yuko Nakano, Tomohiro Kawasaki, Koji Yonemoto, Shoichi Akazawa, Nobuhiko Koga, Hidekazu Tamai
Publikováno v:
Journal of Diabetes Investigation
Aims/Introduction The usefulness of markers of carotid plaque, such as sum (PS) and maximum (P-max) of the plaque thickness, in combination with intima-media thickness in the common carotid artery (CIMT) for the detection of obstructive coronary arte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::584d12d5369fbe1c3feed822153a4ccc
https://doi.org/10.1111/jdi.12403
https://doi.org/10.1111/jdi.12403